Skechers, Inc. (NYSE: SKX) has been an investors’ favourite due to its positive earnings surprises and stable financial performance in the highly competitive footwear market. The sneaker maker is all set to unveil its June-quarter results Thursday after the closing bell. While the outlook remains bullish, the continuing slump in the domestic wholesale business could be a dampener.
The Manhattan Beach, California-based company has been successful in tackling competition and the softness in sales through various steps including cost-cutting. Currently, sales are on the recovery path, reflecting the revamped product line-up and effective management of inventory. Moreover, an increasing number of customers now use the company’s online platform for shopping.
The improvments in the distribution channel and growing international presence, especially in China and Europe, bodes well for the company. These factors could give the top-line a boost in the second quarter. Looking ahead, the management is quite bullish about the overseas operations.
It needs to be seen to what extent the international market would help the company override the slump in the domestic market, especially for the wholesale business. Though the cost-management strategy has helped reduce expenses, elevated general and administrative expenses will eat into margins.
Looking ahead, the management is quite bullish about the company’s international operations
Market watchers are of view that the company will report higher earnings for the second quarter, estimated at $0.34 per share. Supporting the bottom-line, revenues are seen growing 7.4% annually to $1.22 billion. The consensus estimate is slightly above the company’s own guidance for the quarter.
Related: Skechers Q1 2019 Earnings Conference Call Transcript
For the first quarter, the company posted earnings of $0.71 per share, which was lower than $0.75 per share reported a year earlier. However, net sales moved up 2% annually to $1.28 billion during the three-month period.
The recovery of Skechers’ shares, after slipping to a two-year low in December 2018, lost momentum recently. The stock has gained 31% in the past twelve months and 48% since the beginning of 2019.
Most Popular
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with